Ipsen falls on stock market after holding company sells 5%
This article was originally published in Scrip
Executive Summary
Ipsen's share price was down by 3.1% at €36.24 by mid-afternoon on 24 March after the French pharmaceutical company announced that its controlling shareholder Mayroy had sold a stake of around 4.8%.